Aberrant protein prevents self-cleaning of nerve cells in ALS

Scientists have discovered that TDP-43, a nuclear RNA-binding protein that accumulates in amyotrophic lateral sclerosis (ALS), interferes with lysosomal pathways responsible for its clearance and induces autophagy.

Credit: Sebastian Kaulitzki/Shutterstock.com

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that is characterized by a progressive degeneration of motor neurons in the brain and spinal cord, and results in muscle weakness and defective speech and movement.

There is currently no cure for this debilitating condition, which has been widely publicised through its effects on the late British physicist Stephen Hawking.

The nuclear RNA-binding protein TDP-43 is known to accumulate in the cytoplasm of nerve cells in patients with ALS.

The accumulated proteins are often folded incorrectly and clump together. At normal levels, TDP-43 is needed for gene transcription, but when it forms cytoplasmic clumps it damages nerve cells.

A research team at Bayreuth University have been investigating how cells can break down the harmful clumps of TDP-43. They recently discovered cellular processes that may play a key role in the progression of ALS.

It appears that defective TDP‑43 interferes with the lysosomal clearance pathways responsible for the breakdown of TDP-43. The pathogenic TDP‑43 protein thus prevents its own breakdown, whereby disrupting the normal self-cleaning of nerve cells.

Furthermore, In in the absence of normal endolysosomal clearance, TDP-43 induced enhanced cell death.

Christine Leibiger, lead author of this latest research, commented "We are obviously dealing with a pathogenic protein that prevents its own breakdown. The vacuoles in yeast and the lysosomes in humans cannot fulfil their recycling function effectively".

Many research papers addressing the emergence of ALS and the possible therapeutic approaches are mainly interested in the breakdown of TDP‑43 via autophagosomes. In contrast, our study puts the focus on multivesicular bodies, the significance of which may have been underestimated in connection with the self-cleaning powers of nerve cells".

Dr Ralf Braun, Lead Researcher

The team now plan to investigate how the self-cleaning pathways may be reactivated.

Sources:

https://academic.oup.com/hmg/advance-article/doi/10.1093/hmg/ddy066/4892300?guestAccessKey=e1721671-13b7-4422-bf5a-2c1fe575c4ae

https://www.alphagalileo.org/en-gb/Item-Display/ItemId/162160

Kate Bass

Written by

Kate Bass

Kate graduated from the University of Newcastle upon Tyne with a biochemistry B.Sc. degree. She also has a natural flair for writing and enthusiasm for scientific communication, which made medical writing an obvious career choice. In her spare time, Kate enjoys walking in the hills with friends and travelling to learn more about different cultures around the world.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bass, Kate. (2019, June 19). Aberrant protein prevents self-cleaning of nerve cells in ALS. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20180412/Aberrant-protein-prevents-self-cleaning-of-nerve-cells-in-ALS.aspx.

  • MLA

    Bass, Kate. "Aberrant protein prevents self-cleaning of nerve cells in ALS". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20180412/Aberrant-protein-prevents-self-cleaning-of-nerve-cells-in-ALS.aspx>.

  • Chicago

    Bass, Kate. "Aberrant protein prevents self-cleaning of nerve cells in ALS". News-Medical. https://www.news-medical.net/news/20180412/Aberrant-protein-prevents-self-cleaning-of-nerve-cells-in-ALS.aspx. (accessed October 31, 2024).

  • Harvard

    Bass, Kate. 2019. Aberrant protein prevents self-cleaning of nerve cells in ALS. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20180412/Aberrant-protein-prevents-self-cleaning-of-nerve-cells-in-ALS.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A promising new strategy for malaria drug development